Phase 3 N=27 Randomized Treatment

Clinical Trial of Traditional Chinese Diaoshi Jifa Therapy of Meniere's Disease

Meniere's Disease

Bottom Line

View on ClinicalTrials.gov: NCT01454726 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Dec 2012

Primary outcome: Primary: Change in Dizziness Handicap Inventory (DHI) Questionnaire Score — 10.25; 49.6 units on a scale

Study Design & Population

Study type: Interventional
Phase: Phase 3
Interventions: Diaoshi Jifa therapy plus the Western medical treatment. (Other); drug (Other)
Age: Adult, Older Adult · 20+ yrs
Sex: All
Sponsor: Beijing Administration of Traditional Chinese Medicine Bureau
Primary completion: Nov 2011

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Dizziness Handicap Inventory (DHI) Questionnaire Score	10.25; 49.6	—

Summary

The hypothesis of this study is that DiaoShi Jifa reduces the symptoms, such as dizziness in patients with Meniere's disease.

Eligibility Criteria

Inclusion Criteria

Clinical diagnosis of probable Meniere's disease
Must be able to receive manual treatment
Dizziness Patients receiving other treatment longer than 5 days before entering the study.

Exclusion Criteria

Patients with critical illness of internal medicine and surgery
Patients with spinal disease or other conditions that cannot receive manual treatment.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01454726). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.